FdaApplication
ANDA 212936
Identifiers
- fda_app_no: ANDA212936
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-06-08 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 7.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 2.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 10MG | TABLET;ORAL |
4 products